Use of ulipristal to treat uterine fibroids

• 收藏
• 分享

专利权人:

THE U.S.A. AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;LABORATOIRE HRA PHARMA

发明人:

GAINER, ERIN,NIEMAN, LYNNETTE,ULMANN, ANDRE,BLITHE, DIANA

申请号：

ES09706347

公开号：

ES2450592T3

申请日:

2009.01.28

申请国别(地区):

ES

年份:

2014

代理人:

摘要：

Ulipristal acetate (17α-acetoxy-11β- [4-N, N-dimethylaminophenyl) -19-norpregna-4,9-dien-3,20-dione), or any metabolite selected from the group consisting of CBD-3877 , CBD-3963, CBD-3236, and CDB-4183, for use to reduce or stop bleeding in a patient suffering from uterine fibroids.El acetato de ulipristal (17α-acetoxi-11&beta；-[4-N,N-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona), o cualquier metabolito seleccionado del grupo que consiste en CDB-3877, CDB-3963, CDB-3236, y CDB-4183, para su uso para reducir o detener los sangrados en un paciente que padece fibroides uterinos.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/